Depressive disorder

Depressive disorder appears in the book as a condition modern psychedelic research hopes to address, but also as a problem that resists explanation by any single model. The account links it to exploratory treatment research and to a psychoanalytic interpretation of depression, while showing how psychotherapy and meaning-making shape the broader discussion of psychedelic care.

Research and treatment prospects

The book places depression among the conditions researchers were investigating as psychedelic science resumed after the earlier period of sanctioned research had ended. Trials then under way were exploring whether psychedelics—usually Psilocybin rather than LSD—might lift depression and help break addictions. This is presented as a research prospect, not as proof of an established treatment or a report of outcomes from a depression trial.

The surrounding research raises a methodological challenge relevant to such treatment studies. Participants and guides can often tell whether Psilocybin or a placebo was administered, making conventional blinding difficult. Researchers also cannot readily separate the drug’s effects from set and setting, the therapists’ presence, and volunteers’ expectations. The book therefore frames the investigation of psychedelic treatment as more than a test of a molecule in isolation: the experience and the conditions in which it occurs are part of what must be understood.

Competing accounts of depression

A note on Sigmund Freud presents his account of depression, which he called melancholia, as a response to the loss of an object of desire. In this model, the ego divides: one part punishes another that has taken the place of the lost love in the person’s attention. The resulting self-directed punishment is understood as revenge displaced from the lost object onto the self. The book reports this as Freud’s interpretation, rather than establishing it as a complete or current account of depressive disorder.

The text also points to a different kind of inquiry into diagnosis. Tom Insel told the author that algorithms could reliably diagnose depression using the frequency and context of a person’s first-person pronoun use. This example shifts attention from an account of inner conflict to patterns in language, and it underscores the book’s interest in how psychological conditions might be recognized through distinct kinds of evidence.

Psychotherapy, experience, and meaning

A follow-up study of New York University cancer-trial volunteers, led by Alexander Belser, examined the psychological processes associated with changes after Psilocybin-assisted psychotherapy. Its participants had cancer; the study is not presented as a depression trial. The book emphasizes the study’s attention to psychotherapy itself, noting that its title names Psilocybin-assisted psychotherapy rather than the drug alone.

The interviews described participants’ movement from separateness toward connection, often accompanied by joy, love, or bliss. Difficult moments could give way to surrender and acceptance, including acceptance of cancer. Jeffrey Guss interpreted some of these changes through Psilocybin’s capacity to quiet or soften the ego, allowing rigid patterns of thought to loosen. These findings contribute to the book’s broader account of how psychedelic therapy may work, but they should not be mistaken for evidence that the same outcomes were demonstrated in people treated for depression.

Guss’s preparation of volunteers also illustrates how therapists may shape an experience without prescribing a single interpretation. He told patients that the medicine might reveal hidden aspects of themselves and bring insight into life and existence, while allowing them to decide what any mystical or transcendent experience meant. The book presents such guidance as one factor in how participants make meaning, alongside the drug and the therapeutic setting.

Place in the book’s account

Depression is one of three major subjects named in the book’s closing sequence, following dying and addiction. Its treatment is thus part of a larger inquiry into whether psychedelic experiences might help people confronting serious forms of suffering. The evidence presented here remains deliberately plural: psychoanalytic theory, language-based diagnosis, clinical research, and the therapeutic relationship offer different ways to frame the condition, without any one of them being treated as a final explanation.